Hunt Holdings Limited Partnership

Track

Insider profile

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return -12% 8.2% 15.1%
Success rate 7% 68% 82%
Transactions
12 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Hunt Holdings Limited Partnership's trades of Exagen Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Exagen Inc (XGN)
Transaction date
Sale
Price
403.91
Quantity 4,705 +12.9%
Value US$134,302
US Exagen Inc (XGN)
Transaction date
Sale
Price
366.43
Quantity 12,958 +8.1%
Value US$2,088,337
US Exagen Inc (XGN)
Transaction date
Sale
Price
80.61
Quantity 62,092 +4.4%
Value US$3,217,691
US Exagen Inc (XGN)
Transaction date
Sale
Price
16.13
Quantity 30,000 -2.2%
Value US$483,990
US Exagen Inc (XGN)
Transaction date
Sale
Price
16.00
Quantity 30,000 -2.1%
Value US$480,048
US Exagen Inc (XGN)
Transaction date
Sale
Price
16.04
Quantity 15,000 -1.0%
Value US$240,584
US Exagen Inc (XGN)
Transaction date
Sale
Price
16.03
Quantity 7,394 -0.5%
Value US$118,526
US Exagen Inc (XGN)
Transaction date
Sale
Price
16.07
Quantity 15,186 -1.0%
Value US$244,039
US Exagen Inc (XGN)
Transaction date
Sale
Price
16.04
Quantity 10,000 -0.7%
Value US$160,400
US Exagen Inc (XGN)
Transaction date
Sale
Price
16.00
Quantity 150 -0.0%
Value US$2,400
US Exagen Inc (XGN)
Transaction date
Sale
Price
16.06
Quantity 9,045 -0.6%
Value US$145,263
US Exagen Inc (XGN)
Transaction date
Sale
Price
16.04
Quantity 6,752 -0.5%
Value US$108,302
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-01-26 2021-01-25
US Exagen Inc (XGN)
S Sale
4,705 +12.9%
403.91
US$134,302 		4,705 +12.9% 403.91 US$134,302
2021-01-26 2021-01-22
US Exagen Inc (XGN)
S Sale
12,958 +8.1%
366.43
US$2,088,337 		12,958 +8.1% 366.43 US$2,088,337
2021-01-21 2021-01-21
US Exagen Inc (XGN)
S Sale
62,092 +4.4%
80.61
US$3,217,691 		62,092 +4.4% 80.61 US$3,217,691
2021-01-21 2021-01-20
US Exagen Inc (XGN)
S Sale
30,000 -2.2%
16.13
US$483,990 		30,000 -2.2% 16.13 US$483,990
2021-01-21 2021-01-19
US Exagen Inc (XGN)
S Sale
30,000 -2.1%
16.00
US$480,048 		30,000 -2.1% 16.00 US$480,048
2021-01-14 2021-01-12
US Exagen Inc (XGN)
S Sale
15,000 -1.0%
16.04
US$240,584 		15,000 -1.0% 16.04 US$240,584
2021-01-11 2021-01-11
US Exagen Inc (XGN)
S Sale
7,394 -0.5%
16.03
US$118,526 		7,394 -0.5% 16.03 US$118,526
2021-01-11 2021-01-08
US Exagen Inc (XGN)
S Sale
15,186 -1.0%
16.07
US$244,039 		15,186 -1.0% 16.07 US$244,039
2021-01-11 2021-01-07
US Exagen Inc (XGN)
S Sale
10,000 -0.7%
16.04
US$160,400 		10,000 -0.7% 16.04 US$160,400
2020-11-12 2020-11-11
US Exagen Inc (XGN)
S Sale
150 -0.0%
16.00
US$2,400 		150 -0.0% 16.00 US$2,400
2020-11-12 2020-11-10
US Exagen Inc (XGN)
S Sale
9,045 -0.6%
16.06
US$145,263 		9,045 -0.6% 16.06 US$145,263
2020-11-12 2020-11-09
US Exagen Inc (XGN)
S Sale
6,752 -0.5%
16.04
US$108,302 		6,752 -0.5% 16.04 US$108,302